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Abstract
Parkinson´s disease (PD) is characterized by the presence of proteinaceous inclusions
called Lewy bodies that are mainly composed of α-synuclein (αSyn). Elevated levels of oxi-
dative or nitrative stresses have been implicated in αSyn related toxicity. Phosphorylation of
αSyn on serine 129 (S129) modulates autophagic clearance of inclusions and is promi-
nently found in Lewy bodies. The neighboring tyrosine residues Y125, Y133 and Y136 are
phosphorylation and nitration sites. Using a yeast model of PD, we found that Y133 is
required for protective S129 phosphorylation and for S129-independent proteasome clear-
ance. αSyn can be nitrated and form stable covalent dimers originating from covalent cross-
linking of two tyrosine residues. Nitrated tyrosine residues, but not di-tyrosine-crosslinked
dimers, contributed to αSyn cytotoxicity and aggregation. Analysis of tyrosine residues
involved in nitration and crosslinking revealed that the C-terminus, rather than the N-termi-
nus of αSyn, is modified by nitration and di-tyrosine formation. The nitration level of wild-
type αSyn was higher compared to that of A30P mutant that is non-toxic in yeast. A30P
formed more dimers than wild-type αSyn, suggesting that dimer formation represents a cel-
lular detoxification pathway in yeast. Deletion of the yeast flavohemoglobin gene YHB1
resulted in an increase of cellular nitrative stress and cytotoxicity leading to enhanced
aggregation of A30P αSyn. Yhb1 protected yeast from A30P-induced mitochondrial frag-
mentation and peroxynitrite-induced nitrative stress. Strikingly, overexpression of neuroglo-
bin, the human homolog of YHB1, protected against αSyn inclusion formation in
mammalian cells. In total, our data suggest that C-terminal Y133 plays a major role in αSyn
aggregate clearance by supporting the protective S129 phosphorylation for autophagy and
by promoting proteasome clearance. C-terminal tyrosine nitration increases pathogenicity
and can only be partially detoxified by αSyn di-tyrosine dimers. Our findings uncover a
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complex interplay between S129 phosphorylation and C-terminal tyrosine modifications of
αSyn that likely participates in PD pathology.
Author Summary
Parkinson’s disease is characterized by loss of dopaminergic neurons in midbrain and the
presence of αSyn protein inclusions. Human αSyn mimics the disease pathology in yeast
resulting in cytotoxicity and aggregate formation. αSyn is abundantly phosphorylated at
serine S129 and possesses four tyrosines (Y39, Y125, Y133, and Y136) that can be post-
translationally modified by nitration or phosphorylation. The consequence of each of
these possible modifications is still unclear. Nitration as consequence of oxidative stress is
a hallmark for neurodegenerative diseases. Here, we addressed the molecular mechanism,
how tyrosine posttranslational modifications affect αSyn cytotoxicity. Tyrosine nitration
can contribute to αSyn toxicity or can be part of a cellular salvage pathway when di-tyro-
sine-crosslinked dimers are formed. The Y133 residue, which can be either phosphory-
lated or nitrated, determines whether S129 is protectively phosphorylated and αSyn
inclusions are cleared. This interplay with S129 phosphorylation demonstrates a dual role
for C-terminal tyrosine residues. Yeast flavohemoglobin Yhb1 and its human counterpart
neuroglobin NGB protect cells against cytotoxicity and aggregate formation. These novel
insights into the molecular pathways responsible for αSyn cytotoxicity indicate NGB as a
potential target for therapeutic intervention in PD.
Introduction
Parkinson´s disease (PD) is one of the most common neurodegenerative diseases and affects
about 1% of the population older than 60 years [1]. PD proceeds with selective loss of dopa-
mine-producing neurons of the substantia nigra pars compacta in the ventral midbrain [2, 3].
Degeneration also occurs in other neuron types. Particularly, the mid-section of the substantia
nigra (zona compacta) is affected by neurodegeneration, which is accompanied by the loss of
neuromelanin pigment neurons leading to depigmentation [4, 5]. Loss of nigral dopaminergic
neurons consequently results in dopamine depletion in the striatum and generates a wide
range of motoric malfunctions [6]. PD is also described to be associated with non-motoric and
non-dopaminergic symptoms that extend beyond the nigrostriatal dopamine pathway and
often occur years or even decades prior to the clinical diagnosis [7, 8]. Typical hallmark of PD
is the formation of Lewy bodies that can be observed in post mortem brain histology. Lewy bod-
ies are intracellular proteinaceous inclusions with α-synuclein (αSyn) as major constituent [9–
11]. Several independent point mutations in the αSyn encoding gene, as well as duplications or
triplications of the wild-type αSyn locus, have been found in rare familial inherited forms of
PD [12–18]. This makes αSyn a hallmark protein for PD and other related diseases, which are
summarized as synucleinopathies. αSyn is a natively unfolded protein, enriched at presynaptic
nerve terminals. The nuclear localization of αSyn remains under debate, since conflicting
results have been obtained for the existence of αSyn in nuclei of mammalian brain neurons
[19–23]. αSyn was also reported to be localized in the nucleus of cultured neurons, where it
may impair histone acetylation and thereby promote neurotoxicity [24, 25]. αSyn is involved
in the modulation of synaptic activity through regulation of SNARE-complex assembly of
Cross-Talk of α-Synuclein Posttranslational Modifications
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presynaptic vesicles, regulation of neurotransmitter release, regulation of cell differentiation
and phospholipid metabolism [26–31].
Posttranslational modifications (PTMs) play an important role in regulating αSyn aggrega-
tion propensity and cytotoxicity. Major PTMs of αSyn include phosphorylation, ubiquitina-
tion, sumoylation or nitration [32–36]. The predominant αSyn modification is
phosphorylation at serine 129 (S129). More than 90% of αSyn in Lewy bodies is phosphory-
lated at this residue, whereas only 4% of the soluble protein is accordingly modified [37]. The
molecular function of phosphorylation at S129 is still under debate [38]. This modification
modulates clearance of αSyn inclusions in a yeast model of PD [39, 40]. In addition, phosphor-
ylation at S129 can suppress the defects induced by impaired sumoylation such as increased
number of cells with inclusions and reduced yeast growth [41]. These findings support a pro-
tective function for S129 phosphorylation in this model.
Nitrated αSyn represents another PTM discovered in Lewy bodies [33, 34]. Nitration might
be involved in αSyn aggregation, thereby modulating αSyn-induced cytotoxicity. Oxidative
and nitrative stresses are implicated in the pathogenesis of PD [33, 34, 42–45]. Neuroinflam-
mation followed by nitration of αSyn causes accumulation of αSyn aggregates and neurodegen-
eration in mice [46]. Moreover, nitrated αSyn was observed to induce adaptive immune
responses that exacerbate PD pathology in the MPTP mouse model [47]. Increased nitrated
αSyn is present in peripheral blood mononuclear cells of idiopathic PD patients compared to
healthy individuals [48]. These studies provide evidence for a direct link between nitrative
damage and the onset and progression of neurodegenerative synucleinopathies. However, the
precise molecular mechanism that leads to the formation of pathological inclusions is still
elusive.
Exposure of αSyn to nitrative agents results in the formation of αSyn oligomers and higher
molecular weight αSyn species that are resistant to strong denaturing conditions, suggesting
that αSyn proteins are covalently crosslinked [42, 49–52]. This oligomerization can be abol-
ished in vitro when αSyn lacks the four tyrosine residues at positions 39, 125, 133 and 136 [53].
Three of these four tyrosine residues are located at the C-terminal end of αSyn in close neigh-
borhood to the protective S129 phosphorylation site. Nitrating agents such as peroxynitrite/
CO2 (PON) can nitrate tyrosine to generate 3-nitrotyrosine. Alternatively, highly stable o,o’-di-
tyrosine oligomers can be formed, including dimers, trimers and higher oligomeric species [42,
54–56]. However, the majority of the studies were performed in vitro after exposure of αSyn to
nitrating agents leading to non-specific nitration at all tyrosine residues. It is still unclear,
whether the nitration-modified αSyn intermediates are toxic and what are the functional con-
sequences of these modifications. Even the precise positions or preferred combinations for the
tyrosines involved in di-tyrosine formation in vivo are yet unknown.
The yeast Saccharomyces cerevisiae is an established eukaryotic model system used to
uncover the correlation between structural features of αSyn and its toxicity. It provides a
unique tool to study the molecular basis of PD in vivo [57, 58]. 44% of the yeast genes reveal
significant sequence similarities that suggest homology to human genes [59]. The basic molec-
ular machinery necessary for neuronal function is conserved between yeast and humans. Strik-
ingly, heterologous expression of different forms of human αSyn in yeast cells recapitulates
central features of PD, including dose-dependent toxicity and aggregation. Expression of wild-
type αSyn, E46K and A53T mutant results in significant growth inhibition and formation of
inclusions [60, 61]. An unusual feature of the yeast system, which is different from PD and
other models, is that the A30P variant only forms inclusions when highly expressed and fails to
display a growth inhibition in yeast, because aggregation of A30P is only transient [62, 63].
Aggregation of αSyn in yeast cells causes mitochondrial dysfunction or formation of
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chemically reactive molecules, such as reactive oxygen species (ROS) and reactive nitrogen spe-
cies (RNS), which is similar to mammalian cells [60, 64–69].
In this study, we analyzed the effects of nitration of wild-type and A30P mutant αSyn in
yeast cells. We observed that the C-terminus of αSyn is preferentially modified by nitration
compared to the N-terminus in soluble monomers as well as in dimers. Nitro- and phosphate-
groups were found at Y133. Tyrosine nitration leads to increased aggregation and cytotoxicity
of αSyn in yeast and confers toxicity to the non-toxic A30P mutant. The yeast nitric oxide oxi-
doreductase Yhb1 as well as human neuroglobin, which are encoded by homologous genes
conserved from yeast to man, reduced the number of cells with inclusions and protected yeast
from A30P-induced mitochondrial damage. One target of these enzymes is the C-terminal
Y133 and we could show that it is required for protective phosphorylation of αSyn at S129.
Our data revealed a complex choreography of posttranslational events at the αSyn C-terminus
and suggest that tyrosine modifications promote subsequent S129 phosphorylation as part of a
cellular control system, which contributes to the pathogenesis of the disease.
Results
αSyn forms dimers in vivo
Exposure of αSyn to nitrating agents causes tyrosine nitration in vitro and leads to formation
of covalently crosslinked αSyn dimers and inclusions [42, 49, 50, 53, 56]. High levels of αSyn
with C-terminal HIS6-tags were heterologously expressed in yeast cells to uncover how nitra-
tion influences in vivo αSyn toxicity and aggregate formation.
The first approach was to examine whether αSyn and A30P form dimers in vivo without
additional exposure of the cells to nitrating or oxidative agents. αSyn and A30P expression was
driven by the GAL1-promoter which was repressed in the presence of glucose and induced
when shifted to 2% galactose-containing medium for 12 hours (h). High copy number expres-
sion of the HIS6-tagged αSyn resulted in growth inhibition whereas high expression of the
A30P mutant resulted in a similar growth rate as the yeast control without any αSyn (Fig 1A).
Similar results were previously reported with untagged or GFP-tagged αSyn and corroborate
that the HIS6-tag does not interfere with the behavior of αSyn in yeast [60, 63]. αSyn proteins
were enriched by Ni2+ pull-down under denaturing conditions in the presence of urea. Immu-
noblotting with anti-αSyn antibody revealed distinct bands, corresponding to monomeric (~17
kDa), dimeric (~35 kDa) and higher molecular weight αSyn species (oligomers), detected from
in vivo samples (Fig 1B). This supports that αSyn and the A30P mutant form dimers and oligo-
mers in vivo even without additional exposure of the cells to nitrating or oxidative agents.
Dimer and oligomer formation of αSyn in vivo was further analyzed by comparison to addi-
tional in vitro nitration [42]. PON (ONOO-) was applied as nitrating agent for αSyn tyrosine
residues because it leads to the formation of stable αSyn oligomers. PON is formed by the reac-
tion of superoxide (O2-) with the free radical nitric oxide (NO). PON represents a major
nitrating agent that causes tissue injury in several neurological disorders [70, 71]. αSyn and
A30P proteins were expressed in yeast, pulled-down using Ni2+ and exposed to PON. Immu-
noblotting of the in vitro nitrated proteins revealed that the abundance of dimers and oligo-
mers was significantly increased with the same pattern as for in vivo isolated αSyn species (Fig
1B). The major distinct band corresponds to the αSyn dimer species.
Quantification of the dimer band intensities of in vivo isolated probes revealed that A30P
forms approximately twice as many dimers relative to monomers as wild-type αSyn. In vitro
nitration of αSyn and A30P increased the total amount of dimers (Fig 1C). However, the dimer
to monomer ratios between αSyn and A30P were not changed when the in vivo samples were
enhanced by additional in vitro nitration (Fig 1C).
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Our results suggest that the high molecular weight variants of αSyn, which can be isolated
from yeast cells and which withstand strong denaturing conditions during the pull-down (8 M
Urea, 2% SDS), represent covalently crosslinked αSyn species. These data support the forma-
tion of αSyn dimers in living cells. A remarkable result is that the toxicity of αSyn, which corre-
lates to a high protein aggregation rate [63], results in a reduced amount of αSyn dimer relative
to monomer formation. In contrast, the non-toxic A30P mutant that does not inhibit cellular
growth (Fig 1A), and has a reduced aggregation rate, produces twice as many dimers relative to
monomers in comparison to wild-type αSyn. This suggests that αSyn dimer formation is a
molecular mechanism which can be used by the cell as salvage pathway for detoxification.
The C-terminus of αSyn is preferentially modified by nitration and di-
tyrosine formation
Liquid chromatography–mass spectrometry (LC-MS) analysis was performed to analyze αSyn
and A30P nitration sites in vivo. Single trypsin or AspN digestions were employed and the
resulting peptides were analyzed by LC-MS. In addition to single digestions, a combined pro-
teolytic approach by double digestion of the proteins with trypsin and AspN was employed
that enabled 100% sequence coverage. The modifications of the tyrosine residues identified
Fig 1. αSyn forms dimers in vivo. (A) Spotting analysis of yeast cells expressing C-terminally HIS6-tagged αSyn and A30P
αSyn on a high copy vector (2μ) driven by the inducibleGAL1-promoter on non-inducing (´OFF`: glucose) and inducing (´ON`:
galactose) SC-Ura medium after 3 days. Control cells expressed only the empty vector pME2795 (EV). (B) Western blotting of
αSyn and A30P enriched from cell extracts by Ni2+ pull-down with anti-αSyn antibody. In vitro nitration was carried out with
15 μg of αSyn extracts using 1 μl peroxynitrite (PON) in the presence of 1 μl 0.3 M HCl. (C) Quantification of dimers.
Densitometric analysis of the immunodetection of αSyn and A30P αSyn dimers in vivo and in PON-treated samples. The
amount of dimers is presented as percent of the total amount of αSyn detected per lane (monomer + dimer). Significance of
differences was calculated with t-test (**, p < 0.01, n = 4).
doi:10.1371/journal.pgen.1006098.g001
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from fragment spectra are summarized in Fig 2. MS data revealed nitration of wild-type αSyn
at all three C-terminal tyrosines (Y125, Y133, Y136). Nitration of A30P was restricted to Y125
and absent at Y133 or Y136. Nitration of the additional tyrosine residue Y39 in the N-terminal
domain of αSyn could not be identified from any in vivo samples by MS. Pull-down and addi-
tional PON exposure, however, resulted in Y39 nitration in all samples. This suggests that Y39
is not a primary in vivo nitration target within cells. Additional PON-exposure after pull-down
also revealed that the αSyn dimers can be potentially nitrated in vitro. The increased in vitro
PON-mediated nitration of the A30P in comparison to wild-type could be due to the higher
amounts of the dimer in this mutant strain.
Beyond nitration we could also identify phosphorylation in αSyn as well as A30P at S129,
Y125 or Y133 but not at Y39 or Y136 (Table 1). The probabilities for possible phosphorylation
sites were calculated with the phophoRS algorithm [72]. Phosphorylation of Y125 was identi-
fied with only low probability scores (Table 1). In contrast, S129 and Y133 were almost
completely co-phosphorylated with scores of 100% for S129 and 99% for Y133, respectively.
The LC-MS spectra of αSyn and A30P migrating in SDS-PAGE with the size of the dimer
band were analyzed to assess whether di-tyrosines cause dimer formation of αSyn or A30P.
The presence of di-tyrosine peptide crosslinks was validated using StavroX2.3.4.5 software
[73]. This software compares the masses of all potential crosslinked peptides with the precursor
ion masses, calculates b- and y-type ions for all possible crosslinks and compares them to MS2
data of the precursor ion. Different combinations of crosslinked peptides with an identical
mass are possible when multiple tyrosine residues are located on one and the same peptide.
Fig 2. Determination of nitrated peptides from αSyn and A30P. αSyn and A30P were enriched by Ni2+
pull-down from yeast crude extracts and separated by SDS-PAGE. Monomeric and dimeric αSyn stained with
Coomassie were excised from the gel and digested with trypsin and AspN. Untreated (in vivo) and
subsequent peroxynitrite (PON) treated (in vitro) αSyn and A30P protein samples were analyzed with LC-MS
for tyrosine nitration. 3-NT (3-nitrotyrosine) indicates identified nitration sites, supported by at least two
peptides and two independent experiments.
doi:10.1371/journal.pgen.1006098.g002
Table 1. Phospho-peptides identified by MS/MS.
Position Modification PTM Score αSyn PTM Score A30P Sequence Motif
Y39 Phospho 0 1.5 KEGVLyVGSKT
Y125 Phospho 9.7 8 PDNEAyEMPSE
S129 Phospho 100 100 AYEMPsEEGYQ
Y133 Phospho 99,8 100 PSEEGyQDYEP
Y136 Phospho 0 0 EGYQDyEPEA
Posttranslational modification (PTM) scores were calculated with phosphoRS algorithm and represent the probability for phosphorylation modification. The
corresponding amino acid is indicated by a small letter code in the sequence motif. Number of peptide sequence matches: αSyn = 332; A30P = 414.
doi:10.1371/journal.pgen.1006098.t001
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The crosslinked tyrosine pairs were assigned according to the scores calculated by StavroX
based on the fragment ion series of the MS2 spectra. The MS data analysis verified that αSyn
dimers are crosslinked by tyrosine residues. The detected combinations of crosslinked tyrosines
are depicted in Fig 3A. The results indicate a strong preference for crosslinking of defined com-
binations of tyrosines (Figs 3A, 3B, 3C and S1). The most frequent combinations for either
wild-type αSyn or A30P are Y125-Y136 and Y133-Y136 dimers which are all located in the C-
terminus. Only the C-terminal tyrosine residues can mutually interact. Only a small fraction of
Y39-Y39 dimers were found and there are no tyrosine dimers between the N-terminal Y39 and
the C-terminal tyrosines of αSyn or A30P.
Fig 3. Determination of crosslinked peptides from αSyn and A30P. (A) Analysis of di-tyrosine dimers.
Exemplary heat map diagram of the number (N) of identified di-tyrosine crosslinked peptides of the non-treated
αSyn samples. (B) Distribution of all identified di-tyrosine peptides for αSyn. Identified combinations of
crosslinked peptides are presented as percentage of n (n = total number of MS2 spectra verified as crosslinked
peptides). (C) Distribution of all identified di-tyrosine peptides for A30P.
doi:10.1371/journal.pgen.1006098.g003
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These data suggest that the C-terminus of αSyn or A30P has an increased susceptibility for
nitration and di-tyrosine formation compared to the N-terminus. Only Y125 is a major nitra-
tion site of A30P. In contrast, all three C-terminal tyrosines Y125, Y133 and Y136 of the wild-
type αSyn are putative targets for nitration. Y133 is an additional strong and Y125 a weak
phosphorylation site, respectively. Dimer formation through di-tyrosine follows a specific pat-
tern for both tested αSyn proteins with predominant forms including Y136 interacting either
with Y125 (Y125-Y136) or with Y133 (Y133-136).
Tyrosine residues contribute to αSyn-mediated growth inhibition and
aggregate formation
The codons for the four tyrosine sites of αSyn and A30P (Y39, Y125, Y133 and Y136) were
replaced in the corresponding genes by phenylalanine codons (4(Y/F)) to analyze the role of
the tyrosine residues on αSyn dimer formation, cytotoxicity or aggregation. Fusion genes with
GFP-tags or HIS6-tags were constructed and expressed. We assessed whether the quadruple Y
to F replacements influence the dimerization of αSyn and A30P. Expression of αSyn and A30P
as well as their 4(Y/F) mutants was induced for 12 h. Tagged proteins were enriched by Ni2+
pull-down under denaturing conditions. Immunoblotting using αSyn antibodies as well as
antibodies that specifically recognize di-tyrosines revealed that 4(Y/F) mutants of αSyn or
A30P had lost the potential to form dimers in vivo (Fig 4A). Additional in vitro nitration with
PON did also not result in any dimer or oligomer formation and served as control (Fig 4A).
Immunoblotting analysis was carried out to determine in vivo nitrated αSyn using 3-nitro-
tyrosine specific antibodies (Fig 4B). The results demonstrated that the 4(Y/F) variants of wild-
type αSyn or A30P did not result in any nitration signal even after additional PON treatment.
This is in contrast to wild-type αSyn with its four original tyrosine residues as control where
nitration is present in vivo and can be further increased by additional PON treatment.
The growth impact of wild-type αSyn or the A30P variant with that of the additional 4(Y/F)
substitutions were compared by spotting analysis and in liquid medium, respectively (Fig 4C
and 4D). Substitutions of the four tyrosine residues in wild-type αSyn significantly improved
growth on solid medium, whereas A30P αSyn growth was similar with tyrosine or instead with
phenylalanine residues (Fig 4C). Growth in liquid medium resulted in similar effects, revealing
significantly reduced growth inhibition of the 4(Y/F) mutant strain in comparison to wild-type
αSyn, whereas A30P and its A30P/4(Y/F) derivative were growing similarly (Fig 4D).
Next, we assessed whether the decrease in wild-type αSyn toxicity was related to the forma-
tion of αSyn inclusions (Fig 4E and 4F). No change in inclusion formation could be monitored
when A30P was compared to A30P/4(Y/F). However, yeast cells expressing the 4(Y/F) αSyn
variant formed less inclusions in comparison to wild-type αSyn (Fig 4E and 4F). Immunoblot-
ting with αSyn antibody revealed that the protein levels of the different αSyn variants were sim-
ilar (Fig 4G).
Taken together, only tyrosine replacements by phenylalanine in case of wild-type αSyn but
not in case of an additional A30P substitution reduce αSyn-induced toxicity and inclusions for-
mation. Accordingly, there is only growth improvement in the absence of an A30P substitution
that correlates with decrease of intracellular accumulations of αSyn fluorescent foci. This sup-
ports that tyrosine residues that are responsible for nitration of αSyn contribute to the cyto-
toxic effect and inclusion formation of αSyn in yeast. This tyrosine-dependent effect is
significantly less pronounced in the presence of an A30P codon mutation suggesting that A30P
suppresses the tyrosine effect, which can be observed in wild-type αSyn. The presence of tyro-
sine residues in wild-type αSyn favor nitration and di-tyrosine-crosslinking but offer only a
minor contribution to inclusion formation.
Cross-Talk of α-Synuclein Posttranslational Modifications
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The nitric oxide oxidoreductase Yhb1 reduces A30P aggregation and
toxicity
The effect of nitrative stress on the toxicity and aggregation of wild-type and A30P mutant
αSyn was examined. A yeast strain carrying a deletion in the yeast flavohemoglobin gene
(YHB1), responsible for stress signaling, was used for enhancement of nitrative stress. Yhb1 is a
nitric oxide oxidoreductase, which protects against nitration of cellular targets and against cell
growth inhibition under aerobic or anaerobic conditions. Deletion of YHB1 abolishes the nitric
oxide (NO) consuming activity of yeast cells [74]. The compound DETA-NONOate causes
nitrative stress by acting as a NO donor. The absence of the flavohemoglobin results in a
growth impairment of the hypersensitive yhb1 deletion strain in comparison to wild-type
under NO nitrative stress conditions (Fig 5A).
The genes encoding wild-type or A30P αSyn, or GFP as a control, were expressed in Δyhb1
or the isogenic wild-type background. Cell growth was compared in the absence of nitrative
stress by spotting assays (Fig 5B). Wild-type αSyn was as well cytotoxic in the presence or
absence of YHB1. This was different for A30P, where no cytotoxicity was observed in the pres-
ence of YHB1. However, expression of A30P in Δyhb1 cells inhibited cell growth. This effect
was verified by low copy plasmid expression of YHB1. Cells rescued with YHB1 showed the
same growth phenotype as the original A30P or the GFP control in the YHB1 background (Fig
5B).
The correlation between growth inhibition and aggregate formation of αSyn variants was
examined. Cells expressing αSyn or A30P were imaged by fluorescence microscopy and the
cells displaying aggregates were counted. Deletion of YHB1 resulted in increased percentage of
cells with A30P inclusions, whereas no significant difference was observed in cell expressing
wild-type αSyn (Fig 5C). In agreement with the growth analysis, the complementation of the
Δyhb1 deletion by YHB1 rescued the lower aggregation potential of A30P.
Deletion of YHB1 constitutes an internal stress signal. The effect of nitrative stress on A30P
was further investigated by adding external nitrative stress conditions. Growth tests in liquid
culture were performed using DETA-NONOate, which reduces growth of the Δyhb1mutant
but not of the wild-type strain (Fig 5A). Cells expressing A30P αSyn grew uninhibited in the
YHB1 wild-type background, whereas Δyhb1 cells expressing A30P were less inhibited than
αSyn, thus recapitulating the growth phenotype in solid medium (Fig 5B and 5D). In contrast,
Δyhb1 cells expressing both αSyn variants were equally impaired in growth under nitrative
stress conditions (Fig 5D). This indicates that increase in nitrative stress changes A30P to a
toxic protein in yeast cells comparable to wild-type αSyn.
Fig 4. Blocking of αSyn tyrosine nitration decreases aggregation and cytotoxicity. (A) Expression of αSyn, A30P, 4(Y/F) and
A30P/4(Y/F) αSyn was induced for 12 h in galactose-containing medium and the proteins were enriched by Ni2+ pull-down from yeast
cell extracts. For in vitro nitration, 1 μl peroxynitrite (PON) was mixed with 15 μg of αSyn extracts in the presence of 1 μl 0.3 M HCl.
Western blotting with di-tyrosine antibody reveals a major band at about 36 kDa, corresponding to dimers. Additional bands with lower
molecular weights are observed, probably due to intramolecular di-tyrosine crosslinking. The same membrane was stripped and re-
probed with αSyn antibody. (B) Western blotting using 3-nitro-tyrosine antibody (3-NT). Phenylalanine codon substitutions eliminate
immunoreactivity. The samemembrane was stripped and re-probed with αSyn antibody. (C) Spotting analysis of yeast cells
expressingGAL1-driven αSyn, A30P, 4(Y/F), A30P/4(Y/F) αSyn and GFP (control). Yeast cells were spotted in 10-fold dilutions on
SC-Ura plates containing glucose (αSyn ‘OFF’) or galactose (αSyn ‘ON’). (D) Cell growth analysis of yeast cells expressing αSyn,
A30P, 4(Y/F), A30P/4(Y/F) αSyn and GFP (control) in galactose-containing SC-Ura medium for 40 h. Error bars represent standard
deviations of three independent experiments. (E) Fluorescence microscopy of yeast cells, expressing indicated αSyn-GFP variants
after 6 h of induction in galactose-containing medium. Scale bar: 1 μm. (F) Quantification of the percentage of cells displaying
aggregates after 6 h induction in galactose-containing medium. Significance of differences was calculated with t-test (*, p < 0.05,
n = 6). (G) Western blotting analysis of protein crude extracts of GFP-tagged αSyn, 4(Y/F), A30P and A30P/4(Y/F) after 6 h induction in
galactose-containing medium. GAPDH antibody was used as loading control.
doi:10.1371/journal.pgen.1006098.g004
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Fig 5. The nitric oxide oxidoreductase Yhb1 reduces A30P aggregation and toxicity. (A) Cell growth comparison of wild-type YHB1 and
mutant Δyhb1 yeast cells in the presence of the NO stress-mediating drug DETA-NONOate (1 mM) in liquid galactose-containing SC-Ura
medium. Error bars indicate standard deviations of three independent experiments. (B) Spotting analysis of YHB1 and Δyhb1 yeast cells
expressing αSyn (upper boxes) or A30P (lower boxes) compared to GFP and empty vector (EV) as control on non-inducing and galactose-
inducing SC-Ura medium after 3 days. (C) Quantification of the percentage of cells displaying αSyn aggregates after 6 h induction in galactose-
containing medium. Significance of differences was calculated with t-test (**, p < 0.01, n = 6). (D) Cell growth analysis of YHB1 and Δyhb1 yeast
cells expressing αSyn, A30P, 4(Y/F), A30P/4(Y/F) and GFP (control) after 40 h induction in galactose-containing SC-Ura medium. (upper panel,
—DETA-NONOate; lower panel, + 600 μMDETA-NONOate). Error bars show standard deviations of three independent experiments. (E)
Western blotting analysis of protein crude extracts of αSyn and A30P expressed in YHB1 and Δyhb1 yeast after 6 h induction in galactose-
containing medium. GAPDH antibody was used as loading control. (F) Quantification of αSyn and A30P levels in YHB1 and Δyhb1 yeast cells.
Densitometric analysis of the immunodetection of αSyn and A30P relative to the intensity obtained for GAPDH (n = 3).
doi:10.1371/journal.pgen.1006098.g005
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αSyn toxicity is dependent on the expression levels [60, 63]. Thus, it was tested whether the
A30P expression level is equal in Δyhb1mutant compared to YHB1 yeast. Immunoblotting
analysis revealed that the A30P variant was expressed at similar levels in both yeast back-
grounds 6 h after induction of gene expression (Fig 5E and 5F), excluding that differences in
toxicity are due to different A30P expression levels. These results suggest a specific suppressive
function of the nitric oxide oxidoreductase Yhb1 on A30P-induced aggregate formation and
growth inhibition in yeast.
Blockade of tyrosine nitration protects against A30P toxicity and
aggregate formation under nitrative stress
The removal of the four tyrosines of αSyn as possible cellular nitration sites (4(Y/F)) might
affect αSyn toxicity in yeast when the intracellular nitrative stress level is increased using a
Δyhb1 strain defective in stress protection. This was examined by comparing αSyn, A30P and
their 4(Y/F) derivatives which were expressed in yeast with wild-type YHB1 or Δyhb1 deletion
background.
Growth was analyzed by spotting analysis and in liquid medium (Fig 6A and 6B). Expres-
sion of 4(Y/F) αSyn with an intact YHB1 gene resulted in improved growth, whereas A30P tox-
icity was not affected (Figs 6A, 6B, 4C and 4D). In the absence of the YHB1 gene, A30P delayed
growth. However, 4(Y/F) A30P grew similar to the GFP control. A30P-mediated toxicity was
related to the formation of inclusions (Fig 6C).
These results corroborate that increased nitrative stress contributes to A30P toxicity by
nitration of tyrosine residues. Nitration-deficient wild-type or A30P αSyn were less toxic and
aggregated less, whereas an increase of intracellular nitrative stress resulted in growth retarda-
tion and increased aggregate formation of A30P variant only when tyrosine resides were
present.
Yhb1 reduces the accumulation of reactive nitrogen species in A30P
expressing yeast cells
Oxidative and nitrative stresses are implicated in the pathogenesis of PD [75, 76]. These
stresses emerge from the accumulation of reactive intermediates such as ROS and RNS. ROS
and RNS production were visualized in yeast cells. αSyn and A30P expression was induced for
6 h and ROS and RNS specific dyes were applied to compare the production of the reactive spe-
cies in YHB1 and Δyhb1 cells by fluorescence microscopy and flow cytometry.
Dihydrorhodamine 123 (DHR123) was used for ROS detection. The dye accumulates in
cells, where it is oxidized by free radicals to the bright red fluorescent product rhodamine 123
(Fig 7A–7C). Expression of A30P and its derivative A30P/4(Y/F) did not significantly increase
the number of cells accumulating ROS. In contrast, expression of wild-type αSyn as well as its
4(Y/F) derivative strongly increased the number of cells that accumulate red fluorescence
indicative for ROS (Fig 7C). No difference in ROS accumulation was observed between the
YHB1 wild-type and the Δyhb1mutant strain.
DAF-2 DA (4,5-Diaminofluorescein diacetate) dye was used as a sensitive and highly spe-
cific fluorescent indicator for detection of NO (Fig 7D–7F). Expression of both αSyn and A30P
induced accumulation of reactive nitrogen species (Fig 7F). Interestingly, deletion of YHB1 sig-
nificantly increased the number of cells exhibiting RNS when A30P variant was expressed.
This effect was dependent on tyrosine residues since RNS accumulation in cells expressing
A30P/4(Y/F) did not differ from empty vector control.
The results show that toxic wild-type αSyn expression induces significantly more ROS accu-
mulation in yeast cells than non-toxic A30P. Accumulation of ROS species was not dependent
Cross-Talk of α-Synuclein Posttranslational Modifications
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Fig 6. Tyrosinemutation of A30P decreases toxicity in Δyhb1. (A) Spotting analysis of αSyn, A30P, 4(Y/F) αSyn, A30P/4(Y/F) and
GFP (control) expressed in YHB1 and Δyhb1 yeast on non-inducing and galactose-inducing SC-Ura plates after 3 days of growth. (B) Cell
growth analysis of YHB1 and Δyhb1 yeast expressing αSyn, A30P, 4(Y/F), A30P/4(Y/F) and GFP (control) at time point 20 h. Significance
of differences was calculated with t-test (*, p < 0.05; **, p < 0.01, n = 3). (C) Quantification of the percentage of cells displaying αSyn
aggregates after 6 h induction in galactose-containing SC-Ura medium. Significance of differences was calculated with t-test (*, p < 0.05,
**, p < 0.01, n = 6).
doi:10.1371/journal.pgen.1006098.g006
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on the presence of tyrosine residues or YHB1 gene. In contrast, both αSyn as well as A30P
induce the accumulation of RNS for nitrative stress in yeast cells. The levels of RNS in A30P
but not wild-type αSyn expressing cells are dependent on the presence of tyrosine residues and
YHB1. The results suggest that Yhb1 attenuates the accumulation of RNS of A30P expressing
cells.
Yhb1 protects mitochondria from A30P-mediated toxicity
Overexpression of αSyn and A30P leads to increased levels of RNS and higher sensitivity to
NO stress in Δyhb1 yeast. The Yhb1 protein is translocated into yeast mitochondria under hyp-
oxic conditions where it detoxifies NO [77]. Mitochondria are a major source of free radicals in
the cells. Yhb1 is consuming NO, which inhibits mitochondrial respiration and thus increases
the level of ROS. αSyn toxicity results in mitochondrial dysfunction and generation of ROS
[65]. Overexpression of αSyn in mammalian cells results in mitochondrial fragmentation and
involves a direct interaction of αSyn with mitochondrial membranes [78].
We examined whether deletion of YHB1 influences the mitochondrial morphology in αSyn
and A30P αSyn expressing yeast cells. αSyn expression in the wild-type and Δyhb1 background
was induced for 6 h in galactose medium and the mitochondria were visualized with a mito-
chondrial specific dye (MitoTracker Red). Cells expressing GFP were used as a control (Fig
8A). We could not detect co-localization of αSyn with mitochondria, which suggests that the
described mitochondrial fraction of the protein might be small [78]. The mitochondrial mor-
phology was classified as tubular, partially fragmented or fully fragmented. In the control cells,
the mitochondria revealed a ribbon-like tubular architecture, typical for healthy mitochondria.
Cells expressing αSyn showed a dramatic increase in the percentage of cells with fully frag-
mented mitochondria (Fig 8A and 8B). Cells with and without inclusions were considered sep-
arately for statistical evaluation. Cells with plasma-membrane localization of the GFP-signal,
typical αSyn localization for early stages of expression or lower expression levels, revealed par-
tially fragmented mitochondrial architecture. αSyn expressing cells with aggregates had fully
fragmented mitochondria. In contrast to αSyn, A30P expressing cells with aggregates had
mainly tubular mitochondria, similar to the control cells (Fig 8A). Deletion of YHB1 increased
the percentage of cells with fully fragmented mitochondria almost two-fold (Fig 8B). Thus, the
disrupted mitochondrial morphology in Δyhb1 correlates with the increased levels of RNS (Fig
7D–7F) and diminished growth behavior of A30P expressing cells (Fig 5B and 5D). Comple-
mentation of the Δyhb1 phenotype in A30P expressing cells rescued the defect (Fig 8C), as
mitochondrial morphology was recovered by expression of YHB1 on a low-copy vector. The
result suggests that Yhb1 protects against A30P-induced cytotoxicity by preventing the mito-
chondrial fragmentation.
Fig 7. YHB1 deletion increases accumulation of reactive nitrogen species (RNS) in A30P expressing cells. (A) αSyn,
A30P, 4(Y/F) and A30P/4(Y/F) were induced in galactose-containing medium for 6 h in YHB1wild-type or Δyhb1 deletion yeast
strains. Cells were incubated with dihydrorhodamine 123 (DHR123) as an indicator of high intracellular ROS accumulation for 1.5
h and analyzed by live-cell fluorescence microscopy. Scale bar = 5 μm. (B) Fluorescent intensity of cells from (A), assessed with
flow cytometry analysis. Forward scatter (FSC) and DHR123 fluorescence of cells after 6 h induction of αSyn expression. (C)
Quantification of αSyn, A30P, 4(Y/F) and A30P/4(Y/F) expressing cells displaying ROS stained by DHR123 using flow cytometry.
The percentage of the sub-population of yeast cells with higher fluorescent intensities (P1) than the background is presented. (D)
Microscopy analysis of RNS stained cells. αSyn, A30P, 4(Y/F) and A30P/4(Y/F) were induced in galactose-containing SC-Ura
medium for 6 h in YHB1 and Δyhb1 yeast strains. Cells were incubated with DAF-2 DA for 1 h at 30°C for visualization of RNS and
analyzed by live-cell fluorescence microscopy. Scale bar = 5 μm. (E) Fluorescent intensity of cells from (D), assessed with flow
cytometry analysis. Forward scatter (FSC) and DAF-2 DA fluorescence of cells after 6 h induction of αSyn expression. (F)
Quantification of αSyn, A30P, 4(Y/F) and A30P/4(Y/F) expressing cells displaying RNS stained by DAF-2 DA using flow
cytometry. The percentage of the sub-population of yeast cells with higher fluorescent intensities (P1) than the background is
presented. Significance of differences was calculated with t-test (**, p < 0.01, n = 3).
doi:10.1371/journal.pgen.1006098.g007
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Fig 8. Yhb1 protects mitochondria from A30P toxicity. (A) Live-cell fluorescence microscopy of YHB1 compared to Δyhb1 yeast
cells expressing GFP (control), αSyn or A30P after 6 h induction in galactose-containing medium. MitoTracker Red was used to
visualize mitochondria in the cells (MT panel). αSyn expressing cells with plasmamembrane localization (PM) and with aggregates
are visualized. Scale bar = 1 μM. (B) Quantification of yeast cells with tubular mitochondrial network. GFP: percentage of all cells with
tubular mitochondria; αSyn* and A30P*: percentage of cells with aggregates, showing tubular mitochondria. At least 50 cells were
counted per cell type and experiment. Significance of differences was calculated with t-test (*, p < 0.05, n = 4). (C) Quantification of
yeast cells with tubular mitochondrial network for rescue of A30P phenotype. A30P with empty vector (EV) in YHB1 and Δyhb1 strain
and A30P co-transformed with YHB1 on low-copy vector in Δyhb1 strain. A30P*: percentage of cells with aggregates, showing
tubular mitochondria. Significance of differences was calculated with t-test (**, p < 0.01, n = 3).
doi:10.1371/journal.pgen.1006098.g008
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Human neuroglobin protects against αSyn aggregate formation in yeast
and in mammalian cells
A BLAST search for human genes corresponding to yeast YHB1 revealed 49% similarities of
the YHB1 globin domain to human neuroglobin (NGB) as a putative homolog. We analyzed
whether the human counterpart of yeast YHB1 can affect αSyn aggregation. Neuroglobins are
oxygen-binding proteins that are highly conserved among vertebrates and are expressed in the
central and peripheral nervous system. They provide protection against hypoxic induced cell
injury in the brain, which is associated with ROS and RNS accumulation [79]. Both Yhb1 and
neuroglobin contain a globin domain and are members of the globin gene family. NGB was
shown to diminish beta-amyloid-induced neurotoxicity in vitro and to attenuate the pheno-
types in a transgenic mouse model of Alzheimer’s disease [80] and to act as an oxidative stress-
responsive sensor for neuroprotection [81]. Here we examined, whether human NGB affects
αSyn or A30P growth and aggregate formation in yeast. Growth and aggregation of αSyn was
not changed by the expression of the human NGB (Fig 9A and 9B). However, NGB expression
in Δyhb1 deletion strain rescued A30P yeast growth (Fig 9C) and reduced the number of cells
with A30P aggregates (Fig 9D). The effect of NGB in yeast is similar to the impact of YHB1 on
αSyn and A30P growth and aggregate formation (Fig 5C).
Next, we examined whether NGB has not only a protective role against αSyn aggregate
formation in yeast but also in mammalian cells. Human Neuroglioma cells (H4) served as
established αSyn aggregation model, where aggregation of αSyn is induced by co-expressing
C-terminally modified αSyn (SynT) and synphilin-1, αSyn-interacting protein that was also
found in LBs [61, 82]. H4 cells were co-transfected with SynT, synphilin-1 and NGB or empty
vector and aggregate formation of SynT was monitored (Fig 9E and 9F). Expression of NGB
reduced the number of cells with aggregates almost two-fold in comparison to the control and
reduced the number of aggregates per cell. Lactate dehydrogenase (LDH) measurements were
performed to determine, whether there is an effect of NGB on cell toxicity. LDH release into
the cell culture medium is an indicator of damages of the plasma membrane and is used as
cytotoxicity marker. LDHmeasurements were similar for all tested H4 cells and support that
NGB does act as suppressor of αSyn aggregation without significantly causing cytotoxicity.
Yhb1 affects nitration but not dimerization level of αSyn and A30P
We assessed whether the different cytotoxicity of αSyn and A30P in yeast correlates with differ-
ent nitration levels of the two variants in wild-type yeast background and under increased
nitrative stress in Δyhb1 strain. Immunoblotting analysis performed with two specific antibod-
ies against nitro-tyrosine (3-nitrotyrosine and nitro-Y39 αSyn) showed that αSyn and A30P
are nitrated in the YHB1 as well as in Δyhb1 yeast (Fig 10A). Quantification of band intensities
of both nitrated αSyn variants revealed significantly higher nitration level of αSyn in compari-
son to A30P. Deletion of YHB1 resulted in increase of A30P nitration level, whereas αSyn
nitration level was not affected (Fig 10B). The increased nitration level does not correlate with
an increased dimerization level of both αSyn variants. The dimerization was not influenced by
nitrative stress enhancement (Fig 10C and 10D). The results suggest that nitration of αSyn con-
tributes to the cytotoxicity of the protein, whereas dimer formation is in reverse correlation to
toxicity.
Tyrosine 133 is required for phosphorylation of αSyn at serine 129
Phosphorylation of Y125 is required in vitro as a priming event for efficient phosphorylation of
S129 by casein kinase CK1 [83]. Phosphorylation of S129 is the major PTM of αSyn, found in
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Fig 9. The humanNGB gene for neuroglobin alters A30P and αSyn aggregation in yeast andmammalian cells. (A)
Spotting analysis of YHB1 and Δyhb1 yeast cells co-expressing αSyn and GFP (control) with either empty vector as control or
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90% of the aggregated protein in neuronal inclusions of PD patients [37]. αSyn and A30P are
phosphorylated at S129 in yeast by endogenous kinases and phosphorylation has a protective
role against αSyn-induced toxicity and aggregate formation [39, 41]. Given the importance of
these PTM and the close proximity of serine and tyrosine residues at the C-terminus, we
assessed whether there is a cross-talk between modifications of tyrosine residues and phos-
phorylation of αSyn at S129 in vivo.
Immunoblotting with an antibody that specifically recognizes αSyn phosphorylated at Y133
showed that both αSyn and A30P are phosphorylated at these residues, in accordance with our
results fromMS analysis (Fig 11A). Quantification of Y133 phosphorylation revealed similar
phosphorylation level of αSyn and A30P variant both in presence and absence of Yhb1 (Fig
11B). We analyzed whether there is a difference between S129 phosphorylation level of αSyn
and A30P. S129 phosphorylation level of αSyn was much higher than that of A30P (Fig 11A
and 11B). Tyrosine to phenylalanine (Y/F) substitutions were analyzed for their effects on the
phosphorylation level at S129. Y/F mutation of the N-terminal tyrosine 39 as well as of the C-
terminal Y125 and Y136 did not affect the phosphorylation status of S129. In contrast, muta-
tion of Y133 had a drastic impact and resulted in complete loss of phosphorylation at S129 (Fig
11C). Yeast growth was compared in spotting assay as well as in liquid culture between yeast
cells, expressing Y/F single mutants and S129A phosphorylation deficient mutant (Fig 11D
and 11F). Yeast growth was measured after 20 h induction of protein expression. Expression of
Y133F resulted in significant growth inhibition in comparison with αSyn and other tyrosine
mutants. S129A showed slight growth inhibition (Fig 11D and 11F) and significant increase in
the number of cells with aggregates (Fig 11E). In addition to growth analysis, membrane integ-
rity of the Y/F single mutants and S129A phosphorylation deficient mutant was examined to
assess the cell viability of the mutants (Fig 11G and S2 Fig). Propidium iodide (PI) staining was
used after 20 h of protein induction as a sensitive method to determine the fraction of cells
with compromised membrane integrity. Expression of Y133F and S129A significantly dimin-
ished membrane integrity, corroborating that expression of these mutants results in increased
cytotoxicity.
Flow cytometry measurements were performed to determine the accumulation of ROS and
RNS in yeast cells, expressing the single mutants. DHR123 was used for detection of ROS (Fig
12A) and DAF-2 DA was used for detection of RNS (Fig 12B). Expression of all mutants
revealed a significant increase in the levels of ROS and RNS in comparison with the control;
however, no significant differences were observed between the single mutants revealing that
the enhanced toxicity of Y133F and S129A mutant is not due to higher accumulation of ROS
or RNS.
YHB1 andNGB, respectively, on non-inducing and galactose-inducing SC-Ura medium after 3 days. (B) Quantification of the
percentage of cells displaying αSyn aggregates after 6 h induction in galactose-containing medium (n = 3). (C) Spotting
analysis of YHB1 and Δyhb1 yeast cells co-expressing A30P and GFP (control) with either empty vector (pME2788) as
control or YHB1 andNGB, respectively, on non-inducing and galactose-inducing SC-Ura medium after 3 days. (D)
Quantification of the percentage of cells displaying A30P aggregates after 6 h induction in galactose-containing medium.
Significance of differences was calculated with t-test (**, p < 0.01, n = 3). (E) Fluorescence microscopy of H4 cells co-
expressing SynT, synphilin-1 and pcDNA (control) or NGB-mCherry. Nuclei are stained with Hoechst dye (blue). Scale
bar = 30 μm. (F) Quantification of the percentage of H4 cells displaying αSyn inclusions after 48 h after transfection. Cells
were classified into three groups according to the number of αSyn-immunoreactive inclusions observed: cells with 10
inclusions, cells with less than 10 inclusions and cells without inclusions. Significance of differences was calculated with t-test
(*, p < 0.05, n = 3). (G) Lactate dehydrogenase (LDH) activity measurements support that NGB is non-toxic for H4 cells. H4
cells transfected with empty mammalian expression vector pcDNA3.1, with empty pcDNA3.1 or pcDNA3.1 encoding
neuroglobin-mCherry (NGB) together with SynT and synphilin-1 (SynT+Synphilin-1) were analyzed. Media from indicated H4
cells were collected and the secretion of lactate LDH was determined as a measure of cytotoxicity. Significance of differences
was calculated with t-test (not significant (n.s.); n = 3).
doi:10.1371/journal.pgen.1006098.g009
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These results indicate that Y133 is required for the protective effect of αSyn S129 phosphor-
ylation in vivo. Expression of Y133F was more toxic than expression of S129A phosphorylation
deficient mutant, suggesting additional protective contribution of Y133 modifications against
αSyn cytotoxicity. The data support a complex cross-talk between nitration and phosphoryla-
tion of the C-terminal tyrosine residues and S129 phosphorylation of αSyn and A30P.
Fig 10. Yhb1 affects nitration but not dimerization of αSyn and A30P. (A) Immunoblotting analysis of 3-nitrotyrosine using
3-nitrotyrosine antibody (left) and nitro-Y39 αSyn antibody (right). Protein expression was induced for 12 h in galactose-containing
SC-Ura medium. Concentrated protein extracts of Ni2+ pull down-enriched αSyn and A30P αSyn from YHB1 and Δyhb1 yeast cells
were applied. Cells expressing empty vector (EV) served as control. The samemembranes were stripped and re-probed with αSyn
antibody. (B) Quantification of αSyn and A30P nitration levels in YHB1 and Δyhb1 yeast cells. Densitometric analysis of the
immunodetection of nitrated αSyn and A30P relative to the intensity obtained for αSyn. Significance of differences was calculated with
one-way ANOVA with Bonferroni’s multiple comparison test (*, p < 0.05; ****, p < 0.0001; n = 3). (C) Western blotting of αSyn
enriched by Ni2+ pull-down with αSyn antibody. (D) Ratio of dimers relative to the sum of monomers and dimers. Densitometric
analysis of the immunodetection of αSyn and A30P αSyn dimers, presented as percent of the total amount of αSyn detected per lane
(monomer + dimer). Significance of differences was calculated with one-way ANOVA (**, p < 0.01; n = 4).
doi:10.1371/journal.pgen.1006098.g010
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Fig 11. Tyrosine 133 is required for phosphorylation of αSyn at serine 129. (A) Western blotting of αSyn and A30P expressed
in YHB1 and Δyhb1 yeast enriched by Ni2+ pull-down, using Y133 phosphorylation-specific αSyn antibody (pY133) and S129
phosphorylation-specific αSyn antibody (pS129). The samemembrane was stripped and re-probed with αSyn antibody. (B)
Quantification of αSyn and A30P Y133- and S129-phosphorylation levels in YHB1 and Δyhb1 yeast cells. Densitometric analysis of
the immunodetection of pY133, pS129 αSyn and A30P relative to the intensity obtained for αSyn. Significance of differences was
calculated with one-way ANOVA test (**, p < 0.01; n = 4). (C) Western blotting of crude extracts from yeast cells, expressing
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C-terminal αSyn modifications promote autophagy clearance of αSyn
aggregates
GAL1 promoter shut-off experiments were performed to study the role of αSyn PTMs on
autophagy/vacuole and proteasome-mediated aggregate clearance of αSyn. The impact of
blocking these systems by drug treatments was examined. Expression of αSyn was induced for
4 h in galactose-containing medium and the cells were then shifted to glucose-containing
medium in order to repress the promoter. Cells were imaged 4 h after promoter shut-off and
the percentage of cells with inclusions was determined. Shut-off studies were performed with
wild-type αSyn and the mutants 4(Y/F), S129A and Y133F. PMSF was used as an inhibitor of
autophagy/vacuole to study the contribution of this pathway for aggregate clearance [63].
PMSF impairs the activity of many vacuolar serine proteases without affecting proteasome
function [84, 85]. Inhibition of autophagy resulted in inefficient aggregate clearance of αSyn, as
shown previously [41, 63]. Mutations of the codons for the four tyrosines as well as the S129
and Y133 single exchanges resulted in similar aggregate clearance by inhibition of the autopha-
gic proteases as in the control cells without drug (ethanol) (Fig 13A). This suggests that autop-
hagy is less involved in aggregate clearance of these mutants and shows that autophagy-
mediated aggregate clearance requires modifications of the tyrosines and S129. The contribu-
tion of the proteasome on 4(Y/F), S129A and Y133F αSyn aggregate clearance was analyzed by
applying the proteasome inhibitor MG132 [86]. In contrast to autophagy impairment, cells
expressing 4(Y/F) and S129A αSyn cleared inclusions equally as the wild-type αSyn (Fig 13B)
when the proteasome system was impaired. These results corroborate our previous findings
showing a minor contribution of the proteasome to αSyn aggregate clearance [63]. However,
cells expressing the Y133F mutant were unable to clear inclusions in a same manner as the
wild-type, 4(Y/F) and S129A αSyn. This indicates that αSyn, which is not modified at Y133, is
degraded by the proteasomal pathway. The results suggest that PTMs of tyrosine residues and
S129 promote the autophagy-mediated aggregate clearance, whereas non-modified Y133 resi-
due is a key determinant for the targeting of the protein to the proteasome.
Inhibition of autophagy of A30P expressing cells revealed diminished clearance of aggre-
gates of A30P as well as the A30P/4(Y/F) mutant indicating that degradation of the A30P/4(Y/
F) aggregates depends on the autophagy/vacuole system similarly to wild-type αSyn and A30P
(Fig 13C). A30P/S129A and A30P/Y133F mutants were able to degrade aggregates efficiently
upon autophagy inhibition, similar to S129A and Y133F. Proteasome impairment resulted in
inefficient clearance of the A30P/Y133F mutant (Fig 13D). However, this impact was not as
strong as in the αSyn Y133F mutant, confirming that the wild-type αSyn is strongly dependent
on Y133 modification as a determinant for aggregate clearance.
different αSyn variants after 6 h induction of protein expression using S129 phosphorylation-specific αSyn antibody (pS129) and
αSyn antibody. Cells expressing S129A mutant served as control. (D) Spotting analysis of αSyn and indicated mutant strains,
driven by the inducibleGAL1-promoter on non-inducing (´OFF`: glucose) and inducing (´ON`: galactose) SC-Ura medium after 3
days. Cells expressing GFP served as control. (E) Quantification of the percentage of cells displaying αSyn aggregates after 6 h
induction in galactose-containing SC-Ura medium. Significance of differences was calculated with one-way ANOVA (***,
p < 0.001) or Dunnett’s multiple comparison test (#, p < 0.05, ##, p < 0.01 versus αSyn; n = 6). (F) Cell growth analysis of cells
expressing different αSyn variants and GFP (control) after 20 h induction of expression. Significance of differences was calculated
with one-way ANOVA (****, p < 0.0001) or Dunnett’s multiple comparison test (#, p < 0.05; ###, p < 0.001, n = 4). (G)
Quantification of cells expressing different αSyn variants and GFP (control) displaying Propidium Iodide (PI) fluorescence after 20 h
induction of αSyn expression, assessed by flow cytometry. The percentage of PI-positive yeast cells with higher fluorescent
intensities (P1) than the background is presented. Significance of differences was calculated with one-way ANOVA (****,
p < 0.0001) or Dunnett’s multiple comparison test (#, p < 0.05; ###, p < 0.001 versus αSyn; n = 4).
doi:10.1371/journal.pgen.1006098.g011
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Fig 12. Tyrosine 133mutation does not alter the accumulation of reactive oxygen and nitrogen
species. (A, B) Quantification of cells expressing different αSyn variants displaying ROS and RNS assessed
with flow cytometry analysis. αSyn expression was induced for 6 h and the cells were stained for 1.5 h with
DHR123 to visualize ROS (A) or with DAF-2 DA to visualize RNS (B). Forward scatter (FSC) and DHR123 (A)
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Discussion
Phosphorylation at serine residue S129 represents the major protective phosphorylation site of
αSyn which is conserved from man to the baker’s yeast as a eukaryotic Morbus Parkinson cell
model. The effect of nitrative modifications of αSyn and their contribution towards αSyn-
induced cytotoxicity was investigated. A complex interplay was discovered between modifica-
tions of the C-terminal tyrosine residues and S129 phosphorylation (Fig 14). These tyrosine
or DAF-2 DA (B) fluorescence of the cells, showing one representative result from at least four independent
experiments. The percentage of the sub-populations of yeast cells with higher fluorescent intensities (P1)
than the background are presented in the lower panels. Significance of differences was calculated with one-
way ANOVA (****, p < 0.0001).
doi:10.1371/journal.pgen.1006098.g012
Fig 13. αSyn aggregate clearance after promoter shut-off. (A, C) Quantification of cells displaying aggregates of αSyn
(A) and A30P (C) upon inhibition of autophagy by PMSF. Cells expressing αSyn (A) or A30P (C) and its 4(Y/F), S129A
and Y133F variants were incubated in 2% galactose-containing media for 4 h and shifted to 2% glucose-containing media
supplemented with 1 mM PMSF dissolved in EtOH and only EtOH as a control. Cells with aggregates were counted after
4 hGAL1-promoter shut-off and presented as a ratio to the control (EtOH). Significance of differences was calculated with
one-way ANOVA (*, p < 0.05; **, p < 0.01) or Dunnett’s multiple comparison test (#, p < 0.05; ##, p < 0.01 versus αSyn;
n = 4). (B, D) Quantification of cells displaying aggregates of αSyn (B) and A30P (D) upon inhibition of the proteasome by
MG132. Cells expressing αSyn (B) or A30P (D) and the indicated 4(Y/F), S129A and Y133F variants were incubated in
2% galactose-containing media for 4 h and shifted to glucose medium, supplemented with 75 μMMG132, dissolved in
DMSO or only DMSO as a control. Cells with aggregates were counted after 4 hGAL1-promoter shut off and presented as
a ratio to the control (DMSO). Significance of differences was calculated with one-way ANOVA (***, p < 0.001) or
Dunnett’s multiple comparison test (#, p < 0.05; ##, p < 0.01 versus αSyn; n = 4).
doi:10.1371/journal.pgen.1006098.g013
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residues of αSyn can be phosphorylated or nitrated with drastic consequences for cellular
growth. There is a strong preference of the C-terminus of αSyn for nitration or di-tyrosine for-
mation. Nitration interferes with protective phosphorylation of S129, whereas di-tyrosine for-
mation protects yeast cells. The yeast nitric oxidoreductase Yhb1 as well as its related human
protein neuroglobin play protective roles against αSyn aggregation. Yhb1 decreases the nitra-
tion level of the A30P variant of αSyn by reducing the accumulation of reactive nitrogen
Fig 14. αSyn posttranslational modifications and nitrative stress in yeast. Enhanced intracellular
nitrative stress increases the protein nitration level and influences yeast growth and aggregation. The nitration
of tyrosine residues acts as trigger for αSyn and A30P toxicity. Wild-type αSyn, which is highly nitrated,
inhibits growth and shows a high aggregation rate. A30P is weakly nitrated and therefore, does not inhibit
yeast growth and has a low aggregation propensity. Yhb1 and its human homolog NGB protect the cells
against accumulation of nitrative species and diminish the aggregate formation. Di-tyrosine crosslinked
dimers are formed in reverse correlation to cytotoxicity and do not depend on Yhb1. A30P forms twice as
many dimers as the toxic αSyn variant, suggesting that the di-tyrosine crosslinked dimers are not toxic
species and are presumably part of a cellular detoxification pathway, sequestering the protein off-pathway of
αSyn nucleation. The C-terminal tyrosine modifications have dual effect on the toxicity of the protein. Y133,
which is nitrated and phosphorylated, is required for the protective phosphorylation at S129 and for the
autophagy degradation of αSyn aggregates. Non-modified Y133 promotes the proteasomal degradation of
αSyn aggregates. N: nitration; P: phosphorylation.
doi:10.1371/journal.pgen.1006098.g014
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species, resulting that yeast cells can tolerate increased levels of this αSyn variant without sig-
nificant growth inhibition.
In yeast, expression of αSyn triggers accumulation of chemically reactive molecules such as
ROS and RNS that damage the cell by causing oxidative and nitrative stress which in turn con-
tributes to cell death [66]. Nitration reduces the binding affinity of αSyn to lipid vesicles and
therefore disrupts αSyn-membrane interaction [87]. Numerous studies show that oxidative
injury of αSyn, specifically nitration of tyrosine residues, contributes directly to the pathology
of PD. Nitrative stress was proposed to induce αSyn aggregation as well as αSyn-induced
pathology [34, 47, 50, 88–90]. However, also opposing influence of nitrated αSyn has been
shown [51, 52]. Thus, the effect of nitrative αSyn modifications and their influence on the tox-
icity and aggregation of αSyn is still controversial.
In this study, we show that PTMs on αSyn tyrosine residues have a dual impact on αSyn
mediated growth inhibition of yeast cells. Previous studies suggested that nitration of αSyn
might be responsible for the formation of the proteinaceous inclusions observed in PD brains
and for the neuronal loss in the substantia nigra [34, 88]. Here, we showed that nitration
increases the growth defect induced by αSyn in yeast cells. Tyrosine nitration increases aggre-
gation, mitochondrial fragmentation and growth inhibition. We demonstrated a correlation
between the growth impairment, mediated by αSyn and A30P and their nitration level. αSyn,
which inhibits yeast growth and has a high aggregation level, is strongly nitrated. In contrast,
A30P, which is not toxic to yeast and aggregates to a lesser extent, is weakly nitrated.
Notably, we showed that C-terminal tyrosine 133 is required for the protective phosphoryla-
tion of αSyn at S129. αSyn C-terminal tyrosines Y125, Y133 and Y136 are in close proximity to
S129, which raises the question whether there is an interplay between different PTMs at these
residues. S129-phosphorylated αSyn is abundantly found in Lewy bodies [35, 37]. This phos-
phorylation site is conserved in yeast and can be used by several endogenous kinases [91]. The
effects of S129 phosphorylation are complex and the role of this modification on αSyn-induced
toxicity and aggregation is still controversial [38]. In yeast, S129 phosphorylation has a protec-
tive role against growth impairment and aggregate formation [39–41]. Phosphorylation of the
tyrosine residues of αSyn is less explored and the effects of this modification are still unclear,
varying from protective to no impact on neurotoxicity and oligomerization [83, 92–97]. We
show for the first time that tyrosine 133 is strictly required for phosphorylation at S129 in
yeast. Tyrosine 133 can be nitrated or phosphorylated, as demonstrated by immunoblotting
and MS analysis. These two PTMs might have opposing roles on the cellular toxicity of the pro-
tein. Phosphorylation might prevent tyrosine residues from nitration and vice versa. Here, we
used tyrosine to phenylalanine exchanges that abolishes both phosphorylation as well as nitra-
tion. There are no natural amino acids that mimic the phosphorylation or nitration state of the
tyrosine residue, thus restricting the investigation of the contribution of a single posttransla-
tional modification at one and the same tyrosine residue in vivo. Our results reveal Y133 as
major tyrosine phosphorylation site in yeast, and we observe only insignificant phosphoryla-
tion at Y125. Our data reveal a correlation between tyrosine nitration and the cellular S129
phosphorylation level. The wild-type αSyn has significantly higher nitration levels as well as
increased protein populations with S129 phosphorylation but similar levels of Y133 phosphor-
ylation when compared to its A30P variant. These results suggest that rather nitration than
phosphorylation at Y133 promotes S129 phosphorylation in yeast. Alternatively, nitration at
Y133 might change the protein conformation and make S129 more accessible for protein
kinases. The protective effect of Y133 was not accompanied with changes in the potential to
form aggregates. The discrepancy between the clear protective effect of Y133 on yeast growth
without significant effect on inclusion formation suggests that additional yet elusive protective
mechanisms exist in the cell, which do not depend on aggregate formation but support cellular
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survival. This suggests an even more complicated interplay between different α-synuclein mod-
ifications. Recently, the role of site-specific nitration of αSyn was investigated using site-specifi-
cally nitrated synthetic proteins at Y39 and Y125 [98]. The authors assessed the influence of
nitration at Y125 and Y39 on PLK3-mediated in vitro phosphorylation at S129 and showed
that tyrosine nitration does not prevent recognition of the protein by PLK3 and the subsequent
phosphorylation at S129. These results strengthen the link between the C-terminal tyrosine
and serine modifications, revealing a complex cross-talk between PTMs with different contri-
butions to the cytotoxicity of αSyn.
Previously, we have shown that autophagy is the major pathway for aggregate clearance in
yeast [63]. The phosphorylation state of αSyn influences the clearance mechanism of the protein.
Blocking of S129 phosphorylation in yeast leads to impaired aggregate clearance by autophagy
[39]. Increased levels of S129 phosphorylation can suppress the defect of impaired αSyn sumoy-
lation by rescuing the autophagic aggregate clearance and promoting the proteasomal clearance
of αSyn [41]. Here, we show that posttranslational modifications of the four tyrosine residues,
similar to S129 phosphorylation, promote the autophagic clearance of αSyn aggregates. Inhibi-
tion of autophagy rendered yeast cells unable to clear αSyn aggregates, however had no effect on
the clearance of S129A, 4(Y/F) and Y133F mutants. Interestingly, Y133F mutant could not be
degraded upon inhibition of the proteasome. Similarly, proteasome impairment resulted in inef-
ficient clearance of the A30P/Y133F mutant, however the impact was not as strong as in the
αSyn Y133F mutant. Therefore, Y133 represents a key determinant for the degradation fate of
αSyn. Phospho- and nitro-modifications at Y133 promote the autophagic clearance of the aggre-
gates, whereas the non-modified Y133 protein is directed to the proteasome.
Beside nitration, the reaction between tyrosine and RNS can result in the formation of di-tyro-
sine bonds, leading to the formation of stable αSyn oligomers, including dimers and higher oligo-
meric structures. At low peroxynitrite level, di-tyrosine formation outcompetes the reaction of
tyrosine nitration [54, 55] indicating a forced reaction to tyrosine nitration under nitrative stress.
We observed formation of dimers and oligomers in vivo without exposure of yeast cells to nitrat-
ing agents; therefore, they represent the consequence of endogenous nitrative stress. Previous
studies already demonstrated nitration-induced oligomerization of αSyn [42, 53]. There, treat-
ment with nitrating agent resulted in the formation of αSyn dimers and oligomers crosslinked by
di-tyrosine bonds. Using MS, we characterized the tyrosine residues involved in covalent dimer
formation and nitration and identified to what extend the different tyrosine residues are involved
in the di-tyrosine formation and what are the precise positions of the respective tyrosines. To the
best of our knowledge, this is the first characterization of αSyn dimer species, formed in vivo and
without additional exposure to nitrative agents. Our data reveal strong preference of the C-termi-
nal tyrosine residues for dimer formation with predominant forms including Y136 interacting
either with Y125 (Y125-Y136) or with Y133 (Y133-136). Y39 was hardly involved in dimer for-
mation under physiological conditions in yeast or in vitro after PON treatment. Recently, in vitro
studies on αSyn oligomerization and di-tyrosine formation upon treatment with tetranitro-
methane (TMN) demonstrate a predominant formation of di-tyrosine dimers when Y39 is not
available for nitration (Y39F) and suggest that the N-terminal region of αSyn plays a role in
TMN-induced di-tyrosine formation of higher order oligomers [98].
There are studies which described an increase of nitration at Y39 of αSyn in an oxidative
cellular model of PD [99], whereas we observe resistance of Y39 to 3-NT modification in com-
parison to the C-terminal tyrosine residues which are nitrated in vitro as well as in vivo. These
results are corroborated by previous findings, where treatment of purified αSyn with PON did
not result in nitration of Y39; however, all C-terminal residues were nitrated [100]. Higher
nitration levels of αSyn compared to A30P were also detected by mass spectrometry data
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confirming the results from western blot analyses. There, only one tyrosine residue is nitrated
in A30P, whereas three αSyn residues are nitrated.
Our data reveal that αSyn dimers originating from di-tyrosine crosslinking are non-toxic spe-
cies in contrast to nitrated αSyn. Covalent binding of the di-tyrosines stabilizes the dimeric struc-
tures and consequently removes αSyn molecules from aggregation to toxic aggregates. αSyn
protein lacking all four tyrosine residues forms less aggregates, however, the aggregate formation is
not prevented. This indicates that tyrosine residues are not crucial for in vivo assembly of the pro-
tein to aggregates and suggests an independent pathogenic mechanism of αSyn aggregation. Simi-
larly, nitration of αSyn was shown to promote formation of stable off-pathway oligomeric species
that inhibit αSyn fibrillation [51, 52]. Thus, the formation of stable oligomers under oxidative
stress conditions redirects the monomers to oligomers that do not contribute to fibril formation.
Expression of A30P in yeast has different toxicity properties from wild-type αSyn [60, 63].
A30P is located in the cytoplasm, whereas αSyn is delivered to the plasma membrane. Overex-
pression from a high-copy number plasmid results in formation of A30P fluorescent foci, how-
ever, the aggregation is transient and yeast cell growth is not affected. Using the Δyhb1mutant
lacking the flavohemoglobin Yhb1, we could demonstrate that nitration plays also a role for
A30P and confirmed that nitration increases aggregation and growth inhibition. Deletion of
the yhb1 yeast gene results in a deficient cellular detoxification machinery towards NO and
makes A30P as toxic as wild-type αSyn. This shows that the A30P nitration level is a crucial
factor for gaining toxicity. Consequently, elimination of its putative NO-detoxifier Yhb1 results
in stronger formation of toxic αSyn aggregates. Yhb1 reduced the level of nitrative stress in
A30P expressing cells. Moreover, Yhb1 protected the A30P-expressing cells from mitochon-
drial fragmentation. αSyn-induced fragmentation of mitochondrial structure caused by direct
interaction of αSyn with the mitochondrial membranes was already demonstrated [78]. It was
proposed that ROS accumulation induced by αSyn expression is an indirect effect due to mito-
chondrial dysfunction [65]. We found a connection between increased nitrative stress and
mitochondrial fragmentation. This suggests a mechanistic model based on the specific ability
of αSyn and A30P to form aggregates and damage mitochondria induced by nitrative stress.
Analysis of neuroglobin (NGB), the human homologue of YHB1, in human cell lines (H4
cells) confirmed that this protein modulates αSyn aggregation. Expression of neuroglobin in
mammalian cells reduced the number inclusions per cell. Neuroglobin is expressed primarily in
neurons and protects against hypoxic neuronal death and ischemic brain injury [101]. Further-
more, expression of neuroglobin protects against beta-amyloid-induced neurotoxicity in trans-
genic mice in vivo [80]. Recent reports revealed that overexpression of neuroglobin prevents tau
hyperphosphorylation at multiple AD-related sites [102]. These data support our findings and
imply NGB as a new therapeutic target in PD and other neurodegenerative diseases.
A complex interplay between nitration and phosphorylation of αSyn C-terminal residues,
deeply interconnected with nitrative stress, determines the aggregate clearance by autophagy
or ubiquitin-dependent 26S proteasome pathways (Fig 14). The proposed model derived from
yeast as unicellular eukaryotic cell should provide interesting hints and insights for the study of
αSyn posttranslational communications as it happens in the human brain and its connection
to oligomer or aggregate formation and clearance.
Materials and Methods
Plasmid construction, yeast strains, transformation and growth
conditions
Plasmids (Table 2) and Saccharomyces cerevisiae strains (Table 3) used in this work are listed
below. Human αSyn cDNA sequence and the corresponding A30P sequence were expressed
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from yeast high expression vector (2μ) under the GAL1 promoter and CYC1 terminator as
described previously [63]. YHB1 sequence was amplified on genomic DNA from Saccharomy-
ces cerevisiae and NGB was amplified on cDNA sequence and cloned into pME2788 low copy
vector (CEN/ARS) proceeded by GAL1 promoter and followed by CYC1 terminator, respec-
tively. The 4(Y/F) αSyn mutant constructs were generated by site-directed mutagenesis using
QuickChange II Site-Directed Mutagenesis Kit (Agilent Technologies). Plasmids pME3763,
pME3764, pME4095 and pME4101 were used as templates to substitute the four tyrosines
(Y39, Y125, Y133, Y136) by phenylalanine. The same plasmids were used as templates to
Table 2. Plasmids used in this study.
Plasmid Description Source
pME2788 pRS413-GAL1-promoter, CYC1-terminator, HIS3, CEN/ARS, pUC origin, AmpR [104]
pME2795 pRS426-GAL1-promoter, CYC1-terminator, URA3, 2μm, pUC origin, AmpR [104]
pME3759 pME2795 with GAL1::GFP [63]
pME3760 pME2795 with GAL1::SNCAWT [63]
pME3761 pME2795 with GAL1::SNCAA30P [63]
pME3763 pME2795 with GAL1::SNCAWT::GFP [63]
pME3764 pME2795 with GAL1::SNCAA30P::GFP [63]
pME4095 pME2795 with GAL1::SNCAWT::6 x HIS [41]
pME4101 pME2795 with GAL1::SNCAA30P::6 x HIS This study
pME4104 pME2788 with GAL1::NGB This study
pME4351 pME2788 with GAL1::YHB1 This study
pME4352 pME2795 with GAL1::SNCAWTY39/125/133/136F::GFP This study
pME4353 pME2795 with GAL1::SNCAWTY39/125/133/136F::6 x HIS This study
pME4354 pME2795 with GAL1::SNCAA30PY39/125/133/136F::6 x HIS This study
pME4355 pME2795 with GAL1::SNCAA30PY39/125/133/136F::GFP This study
pcDNA3.1 Invitrogen
pME4357 pcDNA3.1 with CMV::NGB::mCherry This study
pME4088 pME2795 with GAL1::SNCAWTY125F::GFP This study
pME4451 pME2795 with GAL1::SNCAWTY39F::GFP This study
pME4452 pME2795 with GAL1::SNCAWTY39F::6 x HIS This study
pME4453 pME2795 with GAL1::SNCAWTY125F::6 x HIS This study
pME4454 pME2795 with GAL1::SNCAWTY125/133/136F::GFP This study
pME4455 pME2795 with GAL1::SNCAWTY125/133/136F::6 x HIS This study
pME4456 pME2795 with GAL1::SNCAWTS129A::GFP This study
pME4457 pME2795 with GAL1::SNCAWTS129A::6 x HIS This study
pME4460 pME2795 with GAL1::SNCAWT Y133F::6 x HIS This study
pME4461 pME2795 with GAL1:: SNCAWT Y133F:: GFP This study
pME4462 pME2795 with GAL1::SNCAWT Y136F::6 x HIS This study
pME4463 pME2795 with GAL1:: SNCAWT Y136F:: GFP This study
pME4466 pME2795 with GAL1:: SNCAA30P S129A:: GFP This study
pME4467 pME2795 with GAL1:: SNCAA30P Y133F:: GFP This study
doi:10.1371/journal.pgen.1006098.t002
Table 3. Yeast strains used in this study.
Strain Genotype Source
BY4741 MATa; his3Δ 1; leu2Δ0; met15Δ0; ura3Δ0 EUROSCARF
Δyhb1 BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0; YGR234w::kanMX4 EUROSCARF
doi:10.1371/journal.pgen.1006098.t003
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substitute serine 129 by alanine. For growth and microscopy studies, αSyn variants were used
that are C-terminally tagged with GFP via the KLID linker [63]. For Ni2+-NTA affinity chro-
matography, αSyn and A30P were C-terminally fused to His6-tag using pME3760 and
pME3761 as templates. All constructs were verified by DNA sequencing.
Saccharomyces cerevisiae strains, BY4741 and Δyhb1, were grown in non-selective medium
(YEPD) at 30°C and transformed by standard lithium acetate protocol [103]. For cultivation of
the Δyhb1 strain, 200 μg/ml G418 were added to the medium. Transformants harboring αSyn
constructs were selected on solid Synthetic Complete medium (SC) lacking uracil (SC-Ura)
supplemented with 2% glucose for 2 days at 30°C. For growth of cells co-expressing αSyn with
YHB1 and NGB, respectively, SC medium lacking uracil and histidine (SC-Ura-His) was used.
Expression of αSyn was induced by shifting overnight cultures from 2% raffinose- to 2% galac-
tose-containing medium (A600 = 0.1).
Spotting assay and growth analysis in liquid culture
To investigate growth on solid medium, cells were pre-grown in selective SC medium contain-
ing 2% raffinose. After normalizing the cells to equal densities (A600 = 0.1), 10-fold dilution
series were prepared and spotted in a volume of 10 μl on SC-Ura or SC-Ura,-His agar plates
supplemented with either 2% glucose or 2% galactose. The growth was documented after incu-
bation for 3 days at 30°C. For growth test in liquid cultures, cell cultures were pre-grown as
described above, adjusted to equal densities of A600 = 0.1 and shifted to galactose-containing
SC-Ura medium. Optical density measurements of 200 μl cell cultures were performed in
96-well plates for 48 h using a microplate reader (Infinite M200; TECAN Group Ltd). Growth
analyses under nitrative stress conditions were performed using either 600 μM or 1 mM
DETA-NONOate (Cayman Chemical Company) as NO donor in SC-Ura medium at pH 7.4.
Fluorescence microscopy, mitochondrial staining and quantifications
Cells were pre-grown in selective SC medium containing raffinose and inoculated in galac-
tose-containing SC medium to an A600 = 0.1. αSyn expression was induced for 6 h and fluo-
rescent images were obtained with 63x magnification using a Zeiss Observer. Z1 microscope
(Zeiss) equipped with a CSU-X1 A1 confocal scanner unit (YOKOGAWA), QuantEM:512SC
digital camera (Photometrics) and SlideBook 6.0 software package (Intelligent Imaging Inno-
vations). Depending on the fluorescent agent, ssGFP or sdRFP filter were applied. To quan-
tify aggregation, at least 300 cells were counted per strain and experiment and the number of
cells displaying αSyn aggregation was referred to the total number of counted cells. To label
mitochondria, the cells were incubated for 45 minutes (min) in the presence of 50 nMMito-
Tracker Red (Molecular Probes, Invitrogen), washed once with fresh medium and imaged.
To test yeast for production of ROS, cells pre-grown overnight in raffinose-containing SC
medium were transferred to galactose-containing SC medium at A600 = 0.1 and incubated for
6 h at 30°C. After washing the cells, dihydrorhodamine 123 (DHR123) Cayman Chemical
Company) was added to a final concentration of 5 μg/ml and the cells were incubated for 1.5
h at 30°C. After washing, the cells were re-suspended in H2O and microscopy was performed
using RFP filter. To test yeast for RNS production, cells pre-grown overnight in raffinose-
containing SC medium were transferred to galactose-containing SC medium at A600 = 0.1.
After 6 h induction cells were washed and diluted in PBS buffer, pH 7.5 to A600 = 0.1. DAF-2
DA (Genaxxon bioscience GmbH) was added to a final concentration of 25 μg/ml and cells
were incubated for 1 h at 30°C in the dark. Before microscopy, the cells were washed and
RNS was visualized using GFP filter.
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Flow cytometry
For testing yeast cells for production of ROS and RNS, flow cytometry was performed. Cells
were grown as above. Before measuring, cells were re-suspended in 50 mM trisodium citrate
buffer, pH 7.0. Flow cytometry analysis was performed on a BD FACSCANTO II (Becton
Dickinson). 100 000 events were counted for each experiment. Data analysis was performed
using the BD FACSDIVA software (Becton Dickinson). Representative examples that are
shown in the Figures were repeated at least 3 times. Yeast cell membrane integrity was analyzed
with PI staining. Yeast cells were incubated with 12.5 μg/ml PI for 30 min. As a positive control,
cells were boiled for 10 min at 95°C.
Promoter shut-off assay and chemical treatments
Yeast cells carrying αSyn were pre-grown in selective SC medium containing 2% raffinose
overnight and shifted to 2% galactose-containing selective SC medium to induce the αSyn
expression for 4 h. Afterwards, cells were shifted to SC medium supplemented with 2% glucose
to shut-off the promoter. 4 h after promoter shut-off, cells were visualized by fluorescence
microscopy. The reduction of number of cells displaying αSyn inclusions was recorded and
plotted on a graph. To study the lysosome/vacuole degradation pathway (autophagy) phenyl-
methanesulfonyl fluoride (PMSF) in ethanol (EtOH) was applied to the suspension in a final
concentration of 1 mM [105]. For impairment of the proteasomal degradation system Carbo-
benzoxyl-leucinylleucinyl-leucinal (MG132) dissolved in dimethyl sulfoxide (DMSO) was
added to the cell suspension in a final concentration of 75 μM and in parallel, equal volume of
DMSO was applied to the cells as a control. For drug treatment with MG132 induction-
medium containing galactose and shut-off-medium containing glucose was supplemented with
0.003% SDS and 0.1% proline [106].
Ni2+-NTA affinity chromatography and In vitro nitration
Purification of His6-tagged recombinant αSyn and A30P was performed using yeast cells carry-
ing the 2μ high-copy vectors pME4095 and pME4101, pME4353, pME4354 and pME2795.
Cells cultured overnight in 200 ml selective SC medium supplemented with 2% glucose were
collected by centrifugation, washed and inoculated in 1.5 liter selective medium containing 2%
galactose for 12 h at 30°C. Cells were lysed by 50 ml 1.85 M NaOH containing 7.5% ß-mercap-
toethanol on ice for 10 min. For precipitation, the protein crude extracts were incubated for 30
min in 50 ml 50% trichloroacetic acid (TCA) on ice, washed afterwards with acetone and dis-
solved in 50 ml buffer A (6 M Guanidine hydrochloride, 100 mMNaH2PO4, 10 mM Tris-HCl,
pH 8.0). The mixture was shaken for 1 h at 25°C, the collected supernatant was calibrated to
pH 7.0 with 1 M Tris base (pH 8.5) and supplemented with imidazole to final concentration of
20 mM. Before the protein crude extract was applied to a His GraviTrap column (GE Health-
care Life Science), the columns were washed with 10 ml buffer A containing 20 mM imidazole
and equilibrated with 5 ml buffer B (8 M Urea, 100 mMNa3PO4, 10 mM Tris, pH 6.3). Elution
of the protein was carried out using 4 times 1 ml of 200 mM imidazole resolved in buffer B.
The protein content of the elution fractions were determined by Bradford protein concentra-
tion assay and subjected to western blot analysis. In vitro nitration of αSyn was performed
using the highly reactive nitrating agent peroxynitrite (PON) (Cayman Chemical Company) in
the presence of 0.3 M HCl to adjust the pH value. 20 μl of the protein were mixed with 1 μl of
both reagents for approximately 10 seconds.
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Immunoblotting
Yeast cells harboring different αSyn constructs were grown in selective SC medium containing
2% raffinose overnight and transferred to 2% galactose-containing medium for induction of
αSyn expression. After expression of αSyn for 6 h, protein crude extracts were prepared and
protein concentration was determined via Bradford protein concentration assay. For electro-
phoretic separations of the protein, 10 μg protein extract was applied to a 12% SDS-polyacryl-
amide-gel and transferred afterwards onto a nitrocellulose or polyvinylidenflouride (PVDF)
membrane. The membrane was incubated with primary antibody diluted in TBST buffer with
5% milk powder overnight. As primary antibodies, rabbit anti α/β/γSyn polyclonal antibody
(1:2000, Santa Cruz Biotechnology), mouse anti 3-nitrotyrosine monoclonal (1:1400, Abcam),
mouse anti nitro-α/ßSyn (Tyr39) monoclonal antibody (1:2000, MERCK), mouse anti di-tyro-
sine monoclonal antibody (1:1000, JaICA), mouse anti phospho Ser-129 αSyn antibody
(1:2500, Wako Chemicals USA), rabbit anti phospho Tyr-133 αSyn polyclonal antibody
(1:1000, Abcam) and mouse anti GAPDHmonoclonal antibody (1:5000, Thermo Fisher Scien-
tific) were used. Peroxidase-coupled goat anti mouse (1:2000, Jackson ImmunoResearch Labo-
ratories) or goat anti rabbit (1:5000, Mobitec) immunoglobulins G was applied as secondary
antibody.
Quantifications of Western Blots
Pixel density values for Western Blot quantification were obtained from TIFF files generated
from digitized x-ray films (Kodak) and analyzed with the ImageJ software (NIH, Bethesda).
Sample density values were normalized to the corresponding loading control. For quantifica-
tion of the signals, at least three independent experiments were performed. The significance of
differences was calculated using Student’s t test or one-way ANOVA test. p value< 0.05 was
considered to indicate a significant difference.
Mass spectrometry analysis
Protein samples were separated by 12% SDS-PAGE. Excised polyacrylamide gel slices of Coo-
massie stained proteins were digested with the proteases trypsin (Promega) and AspN (Sigma-
Aldrich) according to the protocol of Shevchenko [107] and supplier’s instructions. After
digestion and peptide elution the samples were resolved in 20 μl 2.8% acetonitrile containing
0.1% formic acid. The single digestions as well as the double digested AspN/tryptic peptides
were then analyzed by LC-MS.
Peptides of 1–5 μl sample solution were trapped and washed with 0.07% trifluoroacetic acid
2.6% acetonitrile on an Acclaim PepMap 100 column (100 μm x 2 cm, C18, 3 μm, 100 Å, P/
N164535 Thermo Scientific) at a flow rate of 25 μl/min for 5 min. Analytical peptide separation
by reverse phase chromatography was performed on an Acclaim PepMap RSLC column
(75 μm x 25 cm, C18, 3 μm, 100 Å, P/N164534 Thermo Scientific) running a 40 min gradient
from 100% solvent A (0.1% formic acid) to 65% solvent B (80% acetonitrile, 0.1% formic acid)
and further to 95% solvent B within 1 min at flow rates of 300 nl/min (Fisher Chemicals).
Chromatographically eluting peptides were on-line ionized by nano-electrospray (nESI) using
the Nanospray Flex Ion Source (Thermo Scientific) at 2.4 kV and continuously transferred into
the mass spectrometer. Full scans within m/z of 300–1850 were recorded with the Orbitrap-FT
analyzer at a resolution of 30.000 with parallel data-dependent top 10 MS2-fragmentation in
the LTQ Veleo Pro linear ion trap. LC-MS method programming and data acquisition was per-
formed with the software Xcalibur 2.2 (Thermo Fisher). MS/MS2 data processing for protein
analysis and PTM identification was done with the Proteome Discoverer 1.4 (PD, Thermo Sci-
entific) software using the SequestHT search engine (Thermo Scientific) and Saccharomyces
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cerevisiae protein database extended by the most common contaminants with the following cri-
teria: peptide mass tolerance 10 ppm, MS/MS ion mass tolerance 0.8 Da, and up to two missed
cleavages allowed. Only high confident peptides with a false discovery rate less than 0.01 were
considered.
Identification of crosslinked peptides
The MS data of crosslinked peptides were analyzed with StavroX2.3.4.5 [73]. MS data in the
Mascot generic file (mgf) format containing all MS/MS data of precursor ions were loaded into
the program. The following parameters were used for the StavroX analysis: (i) cleavage sites: C-
terminal: K, R; N-terminal: D; (ii) number of missed cleavages = 2; (iii) variable modifications:
oxidation of methionine; nitration of tyrosine; cysteine-to-cysteine acetamid; (iv) mass of
crosslinker: -H2; (v) crosslinks only between two tyrosines; (vi) precision precursor
comparison = 10 ppm.
The false-positive rate was evaluated by decoy analysis using the reversed protein sequence.
The frequency of occurrence of candidates from the data analysis and decoy analysis was com-
pared for each sample. Only scores with decoy frequencies below 8% of the data frequency
were considered as possible crosslinks. The data were filtered for unique scans and each scan
was considered only once with its highest score. Since multiple tyrosine residues are located on
one and the same peptide, different combinations of crosslinked peptides with equal masses
were possible. For each scan the crosslinked tyrosine dimers were assigned according to the
score calculated by the program based on the fragment ions series.
Cell culture
Neuroglioma (H4) cells were plated 24 h prior to transfection, in 12-well plates (Costar). Cells
were transfected with FuGENE6 Transfection Reagent (Promega) using equal amounts of plas-
mid DNA encoding for αSyn, synphilin-1 [108] and Neuroglobin-mCherry, or the empty
mammalian expression vector pcDNA 3.1, according to the manufacturer’s instructions.
Immunocytochemistry
48 h after transfection, cells were washed with PBS and fixed with 4% paraformaldehyde for 10
min at room temperature (RT). After washing with PBS, cells were permeabilized with 0.5%
Triton X-100/PBS (Sigma-Aldrich) for 20 min at RT, and blocked in 1.5% normal goat serum
(PAA)/PBS for 1 h. Cells were incubated with a mouse anti αSyn antibody (1:1000, BD Trans-
duction Laboratory) overnight and then with a secondary antibody (Alexa Fluor 488 donkey
anti-mouse IgG) for 2 h at RT. Finally, cells were stained with Hoechst 33258 (1:5000 in PBS,
Life Technologies- Invitrogen) for 5 min and maintained in PBS prior to epifluorescence
microscopy.
Quantification of αSyn inclusions and cytotoxicity test in H4 cells
Transfected cells were scored based on the αSyn inclusions pattern and classified into: cells
without inclusions, less than ten inclusions (<10 inclusions), and more than ten inclusions
(10 inclusions), as described [61]. The total number of transfected cells was expressed in per-
centage, as the average from three independent experiments. The lactate dehydrogenase (LDH)
cytotoxicity assay (Roche Diagnostics) was performed according to the manufacturer’s instruc-
tions. Growth media from cells were applied in triplicates in a 96-well plate, in a ratio 1:1 with
the reaction mixture. The measurements were performed in a TECAN Infinite 200 Pro plate
reader at 490 nm. The percentage of toxicity was calculated as indicated by the manufacturer.
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Statistical analysis
Data were analyzed using GraphPad Prism 5 (San Diego, California, USA) Software and were
presented as mean ± SEM of at least three independent experiments. The significance of differ-
ences was calculated using Students t-test, one-way ANOVA test with Bonferroni’s multiple
comparison test or Dunnett’s multiple comparison test. P value< 0.05 was considered to indi-
cate a significant difference.
Supporting Information
S1 Fig. MS2 analysis of cross-linked peptides. (A) Exemplary fragment ion MS2 spectrum of
the crosslink between Y133 and Y136 for αSyn dimers. y-ions of the crosslinked peptides are
represented in blue, while b-ions are represented in red. Fragmentation sites are indicated in
the amino acid sequence. (B) Exemplary fragment ion MS2 spectrum of the crosslink between
Y125 and Y136 of A30P dimers.
(PDF)
S2 Fig. Forward scatter (FSC) and Propidium Iodide (PI) fluorescence intensity of cells
assessed with flow cytometry analysis. Cells expressing different αSyn variants and GFP (con-
trol) after 20 h induction of expression were stained with 12.5 μg/ml PI for 30 min. Shown is
one representative result from at least four independent experiments.
(PDF)
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